Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40358
Full Text
Open PDFAbstract
Available in full text
Date
December 29, 2017
Authors
Publisher
Wiley